Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

The Effect of Tele-Counseling Service on Nutrition, Exercise Attitude, and Medication Adherence After Bariatric Surgery

NCT07137117 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-04-15
Last updated
2025-09-03

Condition(s) studied

Bariatric Surgery (Sleeve Gastrectomy )

Investigational drug(s) / intervention(s)

Behavioral Treatment

Behavioral Treatment: Patients in the experimental group will be administered a "Patient Information Form" on the morning of surgery. Standard discharge education will be provided within 72 hours after surgery. After discharge, patients will be contacted at 1, 2, 3 weeks, and 2, 4, and 5 months for informational purposes only; no assessment will be administered. During this period, regular follow-up and support will be provided to enhance patient compliance with post-surgical care. The "Interview Information Collection Form" will be used during telephone interviews with patients to collect and evaluate current health data. This practice will ensure systematic and accurate recording of patients' current conditions. Patients will be contacted at 1, 3, and 6 months to complete the "Medication Adherence Scale" and the "Nutrition and Exercise Attitude Scale," collecting data on medication adherence and behavioral attitudes. These assessments will be used as a systematic approach to monitoring patient adherence t

Study summary

The aim of this study was to evaluate the effects of teleconsultation service on nutrition, exercise attitudes and medication adherence after bariatric surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Patients who have undergone laparoscopic bariatric surgery (sleeve gastrectomy only) for the first time, * Are between the ages of 18 and 65, * Are conscious and oriented to person, time, and place, * Can speak Turkish, * Have no auditory or visual impairments, * Can use a telephone will be included in the study. Exclusion Criteria: * Patients who developed early postoperative complications (bleeding, anastomotic leakage, etc.), were hospitalized for revision surgery, and did not consent to the study will not be included in the study.

Primary outcome measure(s)

  • Medication Adherence Reporting Scale — 6 months
    The Medication Adherence Reporting Scale (IAS) is a scale developed to assess medication adherence. The scale asks participants to evaluate five statements based on their own circumstances. This structure allows for the systematic examination of individual attitudes and behaviors toward medication use. The Medication Adherence Reporting Scale (IAS) is assessed using a 5-point Likert-type rating system, with response options of 5=never, 4=rarely, 3=sometimes, 2=often, and 1=very often. The test score is calculated by summing the scores obtained from the scale items.
  • The Nutrition and Exercise Attitude Scale (NUAS) — 6 months
    The Nutrition and Exercise Attitude Scale (NUAS) was developed in Turkey to measure individuals' attitudes toward nutrition and exercise. Its validity and reliability study was conducted by Yurt (2008). It is structured as a Likert-type scale. This allows individuals to evaluate their own attitudes and behaviors based on various statements. The statements in the scale are rated on a scale according to individuals' level of agreement. Each item in the scale is scored, and a total score is calculated for the subdimensions. Higher scores indicate a more positive attitude in the relevant subdimension. Lower scores indicate that the individual is experiencing difficulties in a particular area. The internal consistency of the scale was assessed using Cronbach's Alpha coefficient and was found to be 0.70. This value indicates that the scale has an acceptable level of internal consistency (Yurt, 2008; Ekici and Yıldız 2018).

Trial sites (1)

FacilityCityRegionStatus
Adana City Training and Research Hospital Adana Yüreğir Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07137117 on ClinicalTrials.gov ↗ ← All trials in Turkey